🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  2. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Body Dysmorphic Disorder

    approved small molecule completed

    1 trial

  3. Fluoxetine + outpatient cognitive behavioral therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    approved small molecule completed

    1 trial

  4. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  5. Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient

    Biocodex

    Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))

    approved small molecule active

    1 trial

  6. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial

  7. IIV4 and PPV23

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza, Human

    approved mab completed

    1 trial

  8. Injectable buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  9. Intravenous fentanyl citrate

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  10. Ketamine Hydrochloride

    NORTHWEST BIOTHERAPEUTICS INC

    Revision Spine Surgery

    approved small molecule active

    1 trial

  11. Kuvan

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria (PKU)

    approved small molecule completed

    2 trials

  12. Kuvan®

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule completed

    2 trials

  13. Liraglutide

    Sana Biotechnology

    Morbid Obesity

    approved small molecule completed

    1 trial

  14. Mailed nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  15. Metformin

    BRIGHT MINDS BIOSCIENCES INC.

    Systemic Inflammation

    approved small molecule active

    1 trial

  16. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule active

    3 trials

  17. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  18. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  19. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Carboxylesterase 1 (CES1) Genotype

    approved small molecule completed

    2 trials

  20. Microcrystalline cellulose, GABAPENTINE BIOGARAN 300 mg, gélule

    The George Institute

    lumbosacral radiculalgia

    approved small molecule active

    1 trial

  21. Mifepristone

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy Related

    approved small molecule completed

    1 trial

  22. Minocycline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  23. Morfina cloridrato S.A.L.F. 10 mg/ml soluzione iniettabile, ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M. 10 mg/ml soluzione iniettabile, CATAPRESAN 150 microgrammi/ml soluzione iniettabile

    Istituto Gentili S.r.l.

    cesarean section

    approved small molecule active

    1 trial

  24. Morphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources